Supplementary materials and methods

Cell culture
HUVEC were maintained in gelatin-coated flasks (0.1% gelatin in distilled water). Trypsin (MP Biomedicals, Illkrich, France) in EDTA was used for the detachment of cells. Cells were seeded at a density of 50, 000 cells/cm 2 on fibronectin-coated (1.5 μg/cm 2 ; Harbor Bio-Products, MA, USA; 2003 & Alfa Aesar, MA, USA; J64560) plates or slides, left to form a confluent monolayer overnight before treatment. All cell cultures were performed in an incubator at 37°C with 5% CO 2 .
Pharmacological inhibition
SB431542 (10 μM; Sigma-Aldrich, Missouri, USA; S4317), 5z-7-oxozeaenol (10 μM; Sigma-Aldrich; O9890), YCG063 (50 μM; Calbiochem, CA, USA; #557354), SB202190 (10 μM; Sigma-Aldrich; S7067) and SC514 (100 μM; Santa Cruz Biotechnology, CA, USA; sc-205504A) were used for inhibition of ALK5, TAK1, ROS production, p38 MAPK and NFкB pathways, respectively. Cells treated with equal volume of dimethyl sulfoxide (DMSO) served as vehicle controls.
Leukocyte-endothelium adhesion assay
Confluent monolayer of HUVEC were stimulated for 48 h with or without 10 ng/ml citric acid activated-TGF-β1 (Peprotech, NJ, USA; #100-21C) in RPMI 1640 basal medium, supplemented with 20% heat-inactivated foetal bovine serum, 2 mM L-glutamine, 5 U/ml heparin and 1% penicillin- 
RT-qPCR
One μg of total RNA was reverse-transcribed using the FirstStrand cDNA synthesis kit (Fermentas with IRDye800 (both 1:10 000; Li-COR Biosciences). The blots were scanned using an Odyssey Infrared Imaging System (Li-COR Biosciences). The intensity of bands was quantified using ImageJ version 1.47 (National Institute of Health, Bethesda, MD, USA).
Supplementary Table S1 . Primer sequences of genes. 
